AI Science Tracker
EN

Machine learning-based prediction of short-term outcomes in aneurysmal subarachnoid hemorrhage: a multicenter study integrating clinical and inflammatory indicators.

Affiliation not stated in the reviewed material · 29 Nov 2025 · medicine

Discovery

Machine learning-based prediction of short-term outcomes in aneurysmal subarachnoid hemorrhage: a multicenter study integrating clinical and inflammatory indicators.

Source check: Source checked. Not independent scientific confirmation.

Finding: development data from four tertiary hospitals (1,120 patients), separate 326-patient Second Xiangya validation; six algorithms, GBM AUC .895 internal and .864 quasi-external. Does not establish clinical impact. Methods/Results: development data from four tertiary hospitals (1,120 patients), separate 326-patient Second Xiangya validation; six algorithms, GBM AUC .895 internal and .864 quasi-external. Testing: Methods/Results: development data from four tertiary hospitals (1,120 patients), separate 326-patient Second Xiangya validation; six algorithms, GBM AUC .895 internal and .864 quasi-external. Does not establish clinical impact.. Multicenter retrospective aSAH model predicts short-term outcomes with internal and quasi-external validation; the external site is described as quasi-external and prospective validation remains needed. Source affiliation was not stated in the reviewed case checks and was unavailable in the local bibliographic cache.

Technology: development data from four tertiary hospitals (1,120 patients), separate 326-patient Second Xiangya validation; six algorithms, GBM AUC .895 internal and .864 quasi-external. Does not establish clinical impact.

Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.

AI contribution
development data from four tertiary hospitals (1,120 patients), separate 326-patient Second Xiangya validation; six algorithms, GBM AUC .895 internal and .864 quasi-external. Does not establish clinical impact.
Test and result
development data from four tertiary hospitals (1,120 patients), separate 326-patient Second Xiangya validation; six algorithms, GBM AUC .895 internal and .864 quasi-external. Does not establish clinical impact.
Limitation / still unknown
Multicenter retrospective aSAH model predicts short-term outcomes with internal and quasi-external validation; the external site is described as quasi-external and prospective validation remains needed.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1186/s12916-025-04523-y

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 4/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.